Skip to main content
Erschienen in: Journal of Radiation Oncology 3/2019

30.08.2019 | Original Research

Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT

verfasst von: Kashmiri L. Chopra, Matthew M. Harkenrider, B. Emami, Edward Melian, Jaiteerth S. Avadhani, T. S. Kehwar, D. V. Rai, Anil Sethi

Erschienen in: Journal of Radiation Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Five dose calculation algorithms commonly used in lung SBRT planning are evaluated for their dosimetric impact on planning target volume (PTV) and organ-at-risk (OAR) doses.

Methods and materials

Treatment plans for thirty lung SBRT patients were included in this multi-institutional planning study. Lung SBRT plans were initially generated using BrainLab Pencil Beam (PB) convolution algorithm to deliver 50 Gy in 5 fractions to PTV (PB_OP plans). Plans were recalculated using BrainLab Monte Carlo (MC) algorithm with the same beam parameters, field settings, and MUs (MC_NO plans) to investigate accuracy limits of PB plans. Next, these plans were re-optimized via MU scaling in MC algorithm while keeping original beam parameters and settings (MC_OP). Further, with these new MUs, all patient plans were recalculated with Pinnacle collapsed cone convolution superposition (CCC), Eclipse anisotropic analytic algorithm (AAA), and Eclipse Acuros XB (AXB) algorithms, and are referred to as AP_NO, AAA_NO, and AXB_NO plans, respectively. DVH of PTV and OARs were used to calculate dosimetric parameters for comparison with MC_OP plans. Patient plans were compared based on PTV size as well as the location in the lung: island targets, adjacent to the ribs/chest wall, or mixed.

Results

Lung SBRT plans using PB dose algorithm overestimated target doses by 10–20% of prescribed dose and these differences were highlighted mainly in the target periphery/dose-buildup region as seen in Dmin and D90. Compared with MC, both Pinnacle and AAA plans overestimated PTV dose in the penumbra region, whereas Acuros plans were in good agreement with MC plans. PTV dose differences ranged 3–5% among Pinnacle, AAA, and Acuros. In general, Acuros AXB performed well for adjacent and mixed targets near the ribs and chest wall, whereas Pinnacle CCC was favored for island targets. OAR Dmax and lung V20 were better reproduced in Pinnacle, whereas Dmean were comparable among all TPS.

Conclusion

Knowing the strengths and limitations of clinical treatment planning system allows more consistent and accurate dose comparison for patients enrolled in protocol studies.
Literatur
1.
Zurück zum Zitat Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37–46CrossRef Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37–46CrossRef
2.
Zurück zum Zitat Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332CrossRef Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332CrossRef
3.
Zurück zum Zitat McGarry RC, Papiez L, Williams M et al (2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63:1010–1015CrossRef McGarry RC, Papiez L, Williams M et al (2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63:1010–1015CrossRef
4.
Zurück zum Zitat Joyner M, Salter BJ, Papanikolaou N, Fuss M (2006) Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45:802–807CrossRef Joyner M, Salter BJ, Papanikolaou N, Fuss M (2006) Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45:802–807CrossRef
5.
Zurück zum Zitat Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC (2006) Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 45:808–817CrossRef Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC (2006) Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 45:808–817CrossRef
6.
Zurück zum Zitat AAPM Radiation Therapy Committee Task Group no. 65, AAPM Report No. 85 (2004) Tissue inhomogeneity corrections for megavoltage photon beams. Medical Physics Publishing, Madison AAPM Radiation Therapy Committee Task Group no. 65, AAPM Report No. 85 (2004) Tissue inhomogeneity corrections for megavoltage photon beams. Medical Physics Publishing, Madison
7.
Zurück zum Zitat Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED (2012) The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 39(3):1386–1409CrossRef Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED (2012) The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 39(3):1386–1409CrossRef
9.
Zurück zum Zitat Lefkopoulos D, Schlienger M, Touboul E, et al. Quantitative evaluation of treatment planning for linac multi-isocentric radiosurgery. Proc. of the XIth Intern. Conf. on: “Computers in radiation therapy,” XIth ICCR, Manchester, UK. 1994; 296–297. Lefkopoulos D, Schlienger M, Touboul E, et al. Quantitative evaluation of treatment planning for linac multi-isocentric radiosurgery. Proc. of the XIth Intern. Conf. on: “Computers in radiation therapy,” XIth ICCR, Manchester, UK. 1994; 296–297.
10.
Zurück zum Zitat Lefkopoulos D, Dejean C, El-Balma H, et al. Determination of dose-volumes parameters to characterize the conformity of stereotactic treatment plans. Proc. of the XIIIth Intern. Conf. on: “computers in radiation therapy,” XIIIth ICCR, Heidelberg, Germany. 2000; 356–358. Lefkopoulos D, Dejean C, El-Balma H, et al. Determination of dose-volumes parameters to characterize the conformity of stereotactic treatment plans. Proc. of the XIIIth Intern. Conf. on: “computers in radiation therapy,” XIIIth ICCR, Heidelberg, Germany. 2000; 356–358.
11.
Zurück zum Zitat Alite F, Jain S, Sethi A, Melian E, Emami B (2014) Impact of Monte Carlo treatment planning on local control in lung SBRT. Int J Radiat Oncol Biol Phys 90(1):S912CrossRef Alite F, Jain S, Sethi A, Melian E, Emami B (2014) Impact of Monte Carlo treatment planning on local control in lung SBRT. Int J Radiat Oncol Biol Phys 90(1):S912CrossRef
12.
Zurück zum Zitat Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CMC, Rogers DWO, Seuntjens J, Sheikh-Bagheri D, Siebers JV (2007) Report of the AAPM task group no. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34:4818–4853. https://doi.org/10.1118/1.2795842 CrossRefPubMed Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CMC, Rogers DWO, Seuntjens J, Sheikh-Bagheri D, Siebers JV (2007) Report of the AAPM task group no. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34:4818–4853. https://​doi.​org/​10.​1118/​1.​2795842 CrossRefPubMed
13.
Zurück zum Zitat Papanikolaou N, Battista JJ, Boyer AL et al (2004) AAPM report 85: tissue inhomogeneity corrections for megavoltage photon beams—report by task group 65 of the Radiation Therapy Committee of the American Association of Physicists in Medicine. Medical Physics Publishing, Madison Papanikolaou N, Battista JJ, Boyer AL et al (2004) AAPM report 85: tissue inhomogeneity corrections for megavoltage photon beams—report by task group 65 of the Radiation Therapy Committee of the American Association of Physicists in Medicine. Medical Physics Publishing, Madison
14.
Zurück zum Zitat Carrasco P, Jornet N, Duch MA, Weber L, Ginjaume M, Eudaldo T, Jurado D, Ruiz A, Ribas M (2004) Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium: dose calculation algorithms in lung heterogeneities. Med Phys 31:2899–2911CrossRef Carrasco P, Jornet N, Duch MA, Weber L, Ginjaume M, Eudaldo T, Jurado D, Ruiz A, Ribas M (2004) Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium: dose calculation algorithms in lung heterogeneities. Med Phys 31:2899–2911CrossRef
15.
Zurück zum Zitat Fogliata A, Vanetti E, Albers D, Brink C, Clivio A, Knöös T, Nicolini G, Cozzi L (2007) On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 52:1363–1385CrossRef Fogliata A, Vanetti E, Albers D, Brink C, Clivio A, Knöös T, Nicolini G, Cozzi L (2007) On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 52:1363–1385CrossRef
16.
Zurück zum Zitat Ojala JJ, Kapanen MK, Hyödynmaa SJ et al (2014) Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 15:4662PubMed Ojala JJ, Kapanen MK, Hyödynmaa SJ et al (2014) Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 15:4662PubMed
19.
Zurück zum Zitat Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR, Salter BJ, Shi J, Xia P, Yue NJ, Xiao Y (2009) IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM task group 119. Med Phys 36(11):5359–5373CrossRef Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR, Salter BJ, Shi J, Xia P, Yue NJ, Xiao Y (2009) IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM task group 119. Med Phys 36(11):5359–5373CrossRef
20.
Zurück zum Zitat Narayanaswamy G, Saenz DL, Defoor D et al (2017) Dosimetric validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 18(6):123–129CrossRef Narayanaswamy G, Saenz DL, Defoor D et al (2017) Dosimetric validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 18(6):123–129CrossRef
21.
Zurück zum Zitat Snyder JE, Hyer DE, Flynn RT, Boczkowski A, Wang D (2019) The commissioning and validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 20(1):184–193CrossRef Snyder JE, Hyer DE, Flynn RT, Boczkowski A, Wang D (2019) The commissioning and validation of Monaco treatment planning system on an Elekta VersaHD linear accelerator. J Appl Clin Med Phys 20(1):184–193CrossRef
Metadaten
Titel
Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT
verfasst von
Kashmiri L. Chopra
Matthew M. Harkenrider
B. Emami
Edward Melian
Jaiteerth S. Avadhani
T. S. Kehwar
D. V. Rai
Anil Sethi
Publikationsdatum
30.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Radiation Oncology / Ausgabe 3/2019
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-019-00399-7

Weitere Artikel der Ausgabe 3/2019

Journal of Radiation Oncology 3/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.